Impact of IFN‐β1a in treatment of a COVID‐19 patient with beta thalassemia and diabetes mellitus: A case report

Impact of IFN‐β1a in treatment of a COVID‐19 patient with beta thalassemia and diabetes mellitus: A case report

Abstract Patients with chronic diseases are severely affected by acute coronavirus syndrome. In this regard, patients with beta thalassemia intermedia and diabetes mellitus (DM) are also at high risk for coronavirus‐induced respiratory failure. The present study aimed to report a case with COVID‐19...

Full description

Bibliographic Details
Main Authors: Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Hanieh Dehghan Chenari
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Clinical Case Reports
Subjects:
beta thalassemia intermedia
COVID‐19
diabetes mellitus
Online Access:https://doi.org/10.1002/ccr3.6114

Similar Items

Similar Items